6A , a decreasing trend was observed for the first group of patients (BS017 and BS019), with a mean of m SEPT9 in plasma from 4.89 at T 0 to 0 at post-treatment time points (T 1 and T 2 ).
← all excerpts
Evaluation of DNA methylation levels of <i>SEPT9</i> and <i>SHOX2</i> in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR.
1
—
—